Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2010
07/14/2010EP2205258A1 Methods and structural conformations of antibody preparations with increased resistance to proteases
07/14/2010EP2205256A2 Reagents for inducing an immune response
07/14/2010EP1863530B1 Methods for damaging cells using effector functions of anti-gfra1 antibodies
07/14/2010EP1734995B1 Monoclonal antibodies to hepatocyte growth factor
07/14/2010CN1671843B Factor participating in transcriptional regulation
07/14/2010CN101778867A Compositions and methods for treating pancreatic tumors
07/14/2010CN101778866A Rsv-specific binding molecules and means for producing them
07/14/2010CN101778865A Polypeptides, antibody variable domains and antagonists
07/14/2010CN101778864A Bone morphogenetic protein (bmp)-binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and use of same
07/14/2010CN101778640A antibody formulations
07/14/2010CN101775372A Anti-testicle-protein hT279 antibody or antibody fragment and application thereof
07/14/2010CN101775371A Anti-testicle-protein hTSC29 antibody or antibody fragment and application thereof
07/14/2010CN101775069A Caustic stable chromatography ligands
07/14/2010CN101773669A HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases
07/13/2010US7754867 Contain an Fc part derived from human origin and do not bind complement factor C1q; for inflammatory and thrombotic disorders such as critical limb ischemia or peripheral arterial occlusive disease; atherosclerosis, thrombosis, restenosis, asthma, arthritis
07/13/2010US7754859 Targeted binding agents directed to PDGFR-alpha and uses thereof
07/13/2010US7754858 Antibodies to tumor necrosis factor receptor associated factor polypeptides
07/13/2010US7754857 Human p51 genes and gene products thereof
07/13/2010US7754856 Human sodium-dependent bile acid transporter proteins
07/13/2010US7754855 comprising a full-length human erythropoietin protein joined without an intervening peptide linker to a human immunoglobulin domain; making fusion proteins comprising a cytokine or growth factor fused to an immunoglobulin domain; treating deficient hematocrit; purification
07/13/2010US7754853 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease
07/13/2010US7754500 combined with bioactive agents for a variety of purposes including drug delivery and conjugation to one member of a binding pair for use in an assay
07/13/2010US7754450 combining immunoglobulin-producing donor cells with immunogenic antigen in vitro, fusing cells with myeloma cells to form parental hybridoma cells (which express a dominant negative allele of a mismatch repair gene), incubating to mutate, then screening for antibodies
07/13/2010US7754418 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders
07/13/2010US7754224 Nucleotide sequences coding glycoprotein for use in vaccine development for prevention of ehrichlia infection; serodiagnostic agents
07/13/2010US7754223 Piscirickettsia salmonis antigens and use thereof
07/13/2010US7754221 A recombinant Lister vaccinia virus, comprising a modified thymidine kinase gene, a modified hemagglutinin gene, and a modified F3gene or locus, each gene or locus is denactivated; the virus comprises heterologous nucleic acid encoding a gene; antitumor,carcinogenic, -proliferative agents; nontoxic
07/13/2010US7754217 HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases
07/13/2010US7754216 treating inflammatory conditions by modulating kallikrein 6 protease activity
07/13/2010US7754215 used for the prevention of acute arterial thrombotic syndromes; do not directly block the GPIb-vWF axis or the GPIIb-IIIa receptor; restenosis, hyperplasia after agioplasty, atherectomy or arterial stenting
07/13/2010US7754214 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis
07/13/2010US7754212 Contraceptives based on SP22 and SP22 antibodies
07/13/2010US7754210 Antibodies binding to RSATEEEPPNDD or DVEDSYGQQWTYEQR peptides (or isoforms/derivatives thereof) of alpha-subunit of (Na++K+)-ATPase, are highly inotropic; both antibodies and peptides are important for treatment of heart failure
07/13/2010US7754209 Molecularly engineered binding domain-immunoglobulin fusion proteins, including single chain Fv-immunoglobulin fusion protein useful for treating malignant conditions and B-cell disorders, such as disease caused by autoantibody production
07/13/2010US7754208 That feature a binding domain for a cognate structure such as an antigen, a counterreceptor or the like, a wild-type IgG1, IGA or IgE hinge region polypeptide or a mutant IgG1 hinge region polypeptide
07/13/2010US7754206 reducing the size of a solid tumor expressing CD44 using Notch4 antagonist
07/13/2010CA2536807C Expression vector
07/13/2010CA2420992C Soluble zalpha11 cytokine receptors
07/13/2010CA2316280C Novel g protein-coupled receptor
07/13/2010CA2286895C Plant fatty acid epoxygenase genes and uses therefor
07/13/2010CA2262893C Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
07/13/2010CA2259724C Monoclonal antibody which is specific for activated coagulation factor vii, and its use
07/13/2010CA2245242C Purified sr-p70 protein
07/13/2010CA2183564C Methods for altering fertility
07/08/2010WO2010078580A2 Immunotherapy for contact dermatitis using co-signal regulation
07/08/2010WO2010078526A1 Anti-lymphotoxin antibodies
07/08/2010WO2010078518A1 Anti-herpes simplex virus antibodies and methods of use thereof
07/08/2010WO2010077854A1 High affinity human antibodies to pcsk9
07/08/2010WO2010077831A1 Targeted cytokine for treatment of diseases
07/08/2010WO2010077634A1 Anti-pd-l1 antibodies and their use to enhance t-cell function
07/08/2010WO2010077473A2 Monoclonal antibodies that react with the capsule of bacillus anthracis
07/08/2010WO2010077323A2 Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders
07/08/2010WO2010076768A1 Isolated peptides of rabbit factor vii
07/08/2010WO2010076618A1 Combination gas vaccines and therapeutics
07/08/2010WO2010076400A1 Use of an anti-cd20 antibody for treating primary intraocular lymphoma
07/08/2010WO2010041938A3 New virulence factors of streptococcus pneumoniae
07/08/2010WO2010037838A3 Cross-species-specific single domain bispecific single chain antibody
07/08/2010WO2010036339A3 A method of detecting antibodies and antibody-hiv virion complexes
07/08/2010WO2010034825A3 Novel antibodies recognizing native annexin a3
07/08/2010WO2010027903A3 Lung cancer diagnosis
07/08/2010WO2009102509A8 Vaccines and diagnostics for ehrlichia chaffeensis
07/08/2010WO2009053604A9 Influenza virus haemagglutinin-specific monoclonal antibodies
07/08/2010US20100174061 Plants which synthesize a modified starch, process for the production thereof and modified starch
07/08/2010US20100174056 Recombinant tumor specific antibody and use thereof
07/08/2010US20100174053 Covalent diabodies and uses thereof
07/08/2010US20100174050 Expression of polypeptides from the nuclear genome of ostreococcus sp
07/08/2010US20100173978 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor
07/08/2010US20100173788 Biomarkers for breast cancer
07/08/2010US20100173428 Protein Phosphorylation By Basophillic Serine/Threonine Kinases
07/08/2010US20100173427 Levetiracetam immunoassays
07/08/2010US20100173384 Methods for protein labeling based on acyl carrier protein
07/08/2010US20100173382 Humanized anti-5t4 antibodies and anti-5t4/calicheamicin conjugates
07/08/2010US20100173367 Functionalized molecules comprising an autosilification moiety and methods of making and using same
07/08/2010US20100173360 Zinc oxide-binding antibody and use thereof
07/08/2010US20100173352 Method for preparing cells for engraftment
07/08/2010US20100173329 Exposed proliferation-related peptides, ligands and methods employing the same
07/08/2010US20100173327 Nonhuman model animal lacking the ability to control lymphocyte migration
07/08/2010US20100173324 Anti-cd27 antibody
07/08/2010US20100173323 Glycosylation engineered antibody therapy
07/08/2010US20100173322 Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
07/08/2010US20100173314 Diagnostic methods using tenascin-w compositions
07/08/2010US20100173297 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
07/08/2010US20100173292 NOVEL GPIIIa GENE
07/08/2010US20100173277 Agent for Suppressing Rejection in Organ Transplantation Comprising Anti-HMGB-1 Antibody
07/08/2010US20100172968 Chimeric cannulae proteins and methods for making and using them
07/08/2010US20100172921 Inhibition of tumor metastasis by anti neuropilin 2 antibodies
07/08/2010US20100172918 Novel lysin protein having broad antibacterial activity specific to bacteria
07/08/2010US20100172917 Binding molecules against SARS-coronavirus and uses thereof
07/08/2010US20100172914 Methods and materials related to trail isoforms
07/08/2010US20100172913 Fibrosis inhibitor
07/08/2010US20100172912 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/08/2010US20100172911 Methods and Vectors for Generating Asialylated Immunoglobulins
07/08/2010US20100172910 Human sarcoma-associated antigens
07/08/2010US20100172908 Methods and compositions for treating diseases targeting maba1
07/08/2010US20100172907 Anti-Abeta antibodies and their use
07/08/2010US20100172906 Anti-herpes simplex virus antibodies and methods of use thereof
07/08/2010US20100172905 Antagonists of hmg1 for treating inflammatory conditions
07/08/2010US20100172903 Combination of an Anti-Ep-CAM Antibody with a Chemotherapeutic Agent
07/08/2010US20100172900 Human Monoclonal Antibodies to BTLA And Methods of Use
07/08/2010US20100172899 IgM Production by Transformed Cell and Method of Quantifying the Same
1 ... 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 ... 1494